What causes patches of dry skin?

Translate to Spanish or other 102 languages!

It can result from a medical condition, such as allergies, dermatitis, and psoriasis. Image for illustration purposes
It can result from a medical condition, such as allergies, dermatitis, and psoriasis. Image for illustration purposes
- Advertisement -

Dry skin patches can have many causes, including cold weather and the chemicals in some soaps and lotions. It can also result from a medical condition, such as allergies, dermatitis, and psoriasis.

Dry skin is a common problem during the winter months when the skin is exposed to colder temperatures and lower moisture levels in the air. In these cases, moisturizer is often enough to soothe and eliminate dry skin patches.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/323973?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -